Visfatin, released in maternal milk at different concentrations related to the maternal conditions, could act as a biomarker with a prognostic/predictive value to determine different newborn clinical conditions, particularly the weight loss of the neonate.
The aim of the study is to analyse a retrospective cohort of well characterized mothers in their post-partum period, and to measure Visfatin levels through collection of maternal milk samples. They will be collected in three different moments after the birth (48 hours, 7 days and 30 days) and Visfatin levels will be analysed through an ELISA kit Adipogen. In parallel, the levels of Visfatin will be evaluated in the maternal plasma/serum collected after 1-2 days postpartum. Lastly, correlations between Visfatin levels and biological/clinical features of mothers and newborns will be explored.
Study Type
OBSERVATIONAL
Enrollment
30
observational study
Ospedale degli Infermi - ASL BI
Ponderano, BI, Italy
RECRUITINGVisfatin levels
Visfatin levels in maternal milk samples
Time frame: 48 hours, 7 days and 30 days
Visfatin levels
Visfatin levels in maternal plasma/serum
Time frame: 1-2 days post-partum
values of Visfatin
correlate the values of Visfatin to different demographic and clinical characteristics of the lactating mothers
Time frame: 6 months
values of Visfatin
correlate the values of Visfatin to different biological/clinical features of the newborns; in particular, we will focus attention on the weight loss of the neonate
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.